文献速递妇科肿瘤

宫颈上皮内瘤变与IA1期宫颈癌局部治疗的比较有效性与早产风险:系统综述与网状Meta分析

Comparative effectiveness and risk of preterm birth of local treatments for cervical intraepithelial neoplasia and stage IA1 cervical cancer: a systematic review and network meta-analysis.
PubMed 文献 · Lancet Oncol · 2022-07-11

该系统综述与网状Meta分析比较了宫颈上皮内瘤变及IA1期宫颈癌不同局部治疗方法的治疗失败与早产风险,检索截至2022年3月9日。治疗失败网络纳入71项研究19240例,早产网络纳入29项研究68817例。与LLETZ相比,激光锥切和冷刀锥切治疗失败风险降低,激光消融和冷冻治疗升高;与未治疗阴道镜组相比,所有切除性技术早产风险升高,消融性方法无差异。

要点

  • 与LLETZ相比,激光锥切(OR 0.59)和冷刀锥切(OR 0.63)治疗失败风险降低,激光消融(OR 1.69)和冷冻治疗(OR 1.84)升高。
  • 与未治疗阴道镜组相比,冷刀锥切(OR 2.27)、激光锥切(OR 1.77)和LLETZ(OR 1.37)早产风险升高,消融性方法无差异。
  • 证据主要基于观察性研究,存在固有偏倚风险,许多比较的可信度低。

核心结论

  • 更根治性的切除技术降低治疗失败风险但增加后续早产风险。
  • 消融治疗可能不增加早产风险,但与切除技术相比失败率更高。
  • LLETZ在有效性与生殖道发病率之间取得平衡,但治疗选择应依据女性年龄、病灶大小和位置以及未来生育计划。

研究设计与样本

  • 系统综述与网状Meta分析,检索MEDLINE、Embase和Cochrane对照试验中心注册库,从建库至2022年3月9日,无语言限制。
  • 纳入CIN、腺上皮内瘤变或IA1期宫颈癌接受切除(冷刀锥切、激光锥切、LLETZ)或消融(根治性电灼、激光消融、冷凝固、冷冻治疗)的女性研究,排除子宫切除者。
  • 治疗失败网络纳入71项研究19240例参与者(25项随机);早产网络纳入29项研究68817例参与者(2项随机)。
  • 主要结局为任何治疗失败(任何异常组织学或细胞学)和早产(<37周妊娠);治疗失败主要参照组为LLETZ,早产主要参照组为未治疗阴道镜组。
  • 对随机对照试验提取组水平汇总数据,对观察性研究提取校正潜在混杂因素后的相对治疗效果估计,采用随机效应网状Meta分析获得OR及95%CI。

主要发现

  • 与LLETZ相比,激光锥切治疗失败风险降低(OR 0.59,95%CI 0.44-0.79),冷刀锥切降低(OR 0.63,95%CI 0.50-0.81)。
  • 与LLETZ相比,激光消融治疗失败风险升高(OR 1.69,95%CI 1.27-2.24),冷冻治疗升高(OR 1.84,95%CI 1.33-2.56)。
  • 冷凝固与LLETZ比较无差异(OR 1.09,95%CI 0.68-1.74),但直接数据仅基于两项小型研究。
  • 与未治疗阴道镜组相比,冷刀锥切早产风险升高(OR 2.27,95%CI 1.70-3.02),激光锥切升高(OR 1.77,95%CI 1.29-2.43),LLETZ升高(OR 1.37,95%CI 1.16-1.62)。
  • 与未治疗阴道镜组相比,消融性方法早产风险无差异:激光消融OR 1.05(95%CI 0.78-1.41),冷冻治疗OR 1.01(95%CI 0.35-2.92),冷凝固OR 0.67(95%CI 0.02-29.15)。

关键数值与推荐

  • 治疗失败定义为任何异常组织学或细胞学。
  • 早产定义为<37周妊娠。
  • 治疗失败主要参照组为LLETZ,早产主要参照组为未治疗阴道镜组。

临床怎么用

  • 作者认为,尽管存在不确定性,消融治疗可能不增加早产风险,但与切除技术相比失败率更高。
  • 作者认为,LLETZ在有效性与生殖道发病率之间取得平衡,但治疗选择应依据女性年龄、病灶大小和位置以及未来生育计划。

局限性

  • 证据主要基于观察性研究,存在固有偏倚风险。
  • 许多比较的可信度低。
  • 冷凝固与LLETZ比较的直接数据仅基于两项小型研究。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The trade-off between comparative effectiveness and reproductive morbidity of different treatment methods for cervical intraepithelial neoplasia (CIN) remains unclear. We aimed to determine the risks of treatment failure and preterm birth associated with various treatment techniques. METHODS: In this systematic review and network meta-analysis, we searched MEDLINE, Embase, and the Cochrane Central Register of Controlled Trials database for randomised and non-randomised studies reporting on oncological or reproductive outcomes after CIN treatments from database inception until March 9, 2022, without language restrictions. We included studies of women with CIN, glandular intraepithelial neoplasia, or stage IA1 cervical cancer treated with excision (cold knife conisation [CKC], laser conisation, and large loop excision of the transformation zone [LLETZ]) or ablation (radical diathermy, laser ablation, cold coagulation, and cryotherapy). We excluded women treated with hysterectomy. The primary outcomes were any treatment failure (defined as any abnormal histology or cytology) and preterm birth (<37 weeks of gestation). The network for preterm birth also included women with untreated CIN (untreated colposcopy group). The main reference group was LLETZ for treatment failure and the untreated colposcopy group for preterm birth. For randomised controlled trials, we extracted group-level summary data, and for observational studies, we extracted relative treatment effect estimates adjusted for potential confounders, when available, and we did random-effects network meta-analyses to obtain odds ratios (ORs) with 95% CIs. We assessed within-study and across-study risk of bias using Cochrane tools. This systematic review is registered with PROSPERO, CRD42018115495 and CRD42018115508. FINDINGS: 7880 potential citations were identified for the outcome of treatment failure and 4107 for the outcome of preterm birth. After screening and removal of duplicates, the network for treatment failure included 19 240 participants across 71 studies (25 randomised) and the network for preterm birth included 68 817 participants across 29 studies (two randomised). Compared with LLETZ, risk of treatment failure was reduced for other excisional methods (laser conisation: OR 0·59 [95% CI 0·44-0·79] and CKC: 0·63 [0·50-0·81]) and increased for laser ablation (1·69 [1·27-2·24]) and cryotherapy (1·84 [1·33-2·56]). No differences were found for the comparison of cold coagulation versus LLETZ (1·09 [0·68-1·74]) but direct data were based on two small studies only. Compared with the untreated colposcopy group, risk of preterm birth was increased for all excisional techniques (CKC: 2·27 [1·70-3·02]; laser conisation: 1·77 [1·29-2·43]; and LLETZ: 1·37 [1·16-1·62]), whereas no differences were found for ablative methods (laser ablation: 1·05 [0·78-1·41]; cryotherapy: 1·01 [0·35-2·92]; and cold coagulation: 0·67 [0·02-29·15]). The evidence was based mostly on observational studies with their inherent risks of bias, and the credibility of many comparisons was low. INTERPRETATION: More radical excisional techniques reduce the risk of treatment failure but increase the risk of subsequent preterm birth. Although there is uncertainty, ablative treatments probably do not increase risk of preterm birth, but are associated with higher failure rates than excisional techniques. Although we found LLETZ to have balanced effectiveness and reproductive morbidity, treatment choice should rely on a woman's age, size and location of lesion, and future family planning. FUNDING: National Institute for Health and Care Research: Research for Patient Benefit.

来源:Lancet Oncol,查看原文。版权归原作者所有。

引用

  1. Athanasiou A, Veroniki AA, Efthimiou O, et al. Comparative effectiveness and risk of preterm birth of local treatments for cervical intraepithelial neoplasia and stage IA1 cervical cancer: a systematic review and network meta-analysis. Lancet Oncol. 2022. PMID: 35835138. doi:10.1016/S1470-2045(22)00334-5

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。